Clinical Trials Browser

Phase 3 × Lymphoma, Extranodal NK-T-Cell × Thalidomide × Clear all

NCT02085655 2021-03-15

PEG-ASP+Gemox Regimen and Thalidomide for NK/T Lymphoma

Phase 3 Unknown

Lymphoma, Extranodal NK-T-Cell